Cargando…
Synergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment
Chronic myeloid leukemia (CML) is effectively treated with tyrosine kinase inhibitors (TKIs), targeting the BCR::ABL1 oncoprotein. Still, resistance to therapy, relapse after treatment discontinuation, and side effects remain significant issues of long-term TKI treatment. Preliminary studies have sh...
Autores principales: | Häselbarth, Lukas, Gamali, Sara, Saul, Domenica, Krumbholz, Manuela, Böttcher-Loschinski, Romy, Böttcher, Martin, Zou, Deyu, Metzler, Markus, Karow, Axel, Mougiakakos, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680331/ https://www.ncbi.nlm.nih.gov/pubmed/38012567 http://dx.doi.org/10.1186/s12885-023-11623-6 |
Ejemplares similares
-
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib
por: Häselbarth, Lukas, et al.
Publicado: (2023) -
Lipotoxicity as a Barrier for T Cell-Based Therapies
por: Böttcher-Loschinski, Romy, et al.
Publicado: (2022) -
IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner
por: Loschinski, Romy, et al.
Publicado: (2018) -
TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
por: Jantz-Naeem, Nouria, et al.
Publicado: (2023) -
CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints
por: Böttcher, Martin, et al.
Publicado: (2022)